Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Drug Carriers In Osteoporosis: Preparation, Drug Encapsulation And Applications.

K. Miladi, S. Sfar, H. Fessi, A. Elaissari
Published 2013 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Carriers are largely used to enhance therapy efficiency via the encapsulation of active molecules. The encapsulation enhances the stability of drug molecules, improves the targeting properties and prolongs pharmacological activity via continuous local release of active molecules. The aim of this review is to report the carrier systems used in osteoporosis therapy. This state of the art research has mainly focused on describing all types of carriers used in this area, their elaboration and properties, the drug characteristics used in such specific application, and drug release and efficiency. In this field, various processes have been used in order to obtain well-defined capsules, spheres and more complex carriers. In this exhaustive review, each process is described, illustrated and discussed.
This paper references
10.1016/S0377-1237(10)80050-4
Prevalent and Emerging Therapies for Osteoporosis.
K. Brar (2010)
Sucessful strategy for
D. O. Cintra e Silva (2012)
10.1002/ADMA.200306340
Chemically Modified Calcium Phosphates as Novel Materials for Bisphosphonate Delivery
S. Josse (2004)
10.1016/0378-5173(91)90172-K
Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release
N. Brasseur (1991)
10.1208/s12249-008-9097-x
Conventional and Dense Gas Techniques for the Production of Liposomes: A Review
Louise A. Meure (2008)
10.1016/j.maturitas.2010.05.009
SERMs: progress and future perspectives.
J. Pickar (2010)
10.1016/j.jconrel.2011.10.001
Bone targeting for the treatment of osteoporosis.
T. Luhmann (2012)
10.1016/0031-6865(95)00010-7
Preparation and characterization of liposomes as therapeutic delivery systems: a review.
S. Vemuri (1995)
10.1016/J.POWTEC.2012.01.045
Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation
Somayeh Jafarinejad (2012)
10.3109/9781420078053
Drug Delivery Nanoparticles Formulation and Characterization
Y. Pathak (2009)
10.1016/J.PROENG.2011.11.056
Effect of Temperature on Emulsion Polymerization of n-Butyl Acrylate
Guangfeng Wu (2011)
10.1002/jps.21886
Spray drying technique. I: Hardware and process parameters.
K. Cal (2010)
10.1016/S0939-6411(01)00245-4
Factors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerisation of water-in-oil microemulsions.
T. Pitaksuteepong (2002)
10.1016/j.ijpharm.2010.04.034
N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34.
Sheng-hao Zhao (2010)
used the adsorption method to prepare oly(isobutylcyanoacrylate) nanoparticles loaded with CT. A ercentage of binding of CT to the polymer of 96.3% was btained
Calcitonin Tasset (1995)
10.1016/J.NANO.2006.11.008
The present and future of nanotechnology in human health care.
S. Sahoo (2007)
10.3109/02652048.2012.655428
Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis
S. Sultana (2012)
10.1016/j.ejps.2010.06.020
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates.
V. Dissette (2010)
10.1016/J.ADDR.2005.07.006
Comparison of the mucoadhesive properties of various polymers.
V. Grabovac (2005)
10.1016/S0378-5173(96)04697-2
Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique
D. Quintanar-Guerrero (1996)
10.1016/j.nano.2009.04.007
Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method.
M. R. Avadi (2010)
10.1016/j.ejpb.2011.07.010
Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
Maha Nasr (2011)
10.4155/TDE.12.55
Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS.
M. Gagliardi (2012)
10.3109/02652048.2011.621551
In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin
X. Huang (2012)
10.1016/0378-5173(95)04300-4
Chitosan beads for the delivery of salmon calcitonin : preparation and release characteristics
Z. Aydin (1996)
10.1023/A:1016278902839
Adsorption of Salmon Calcitonin to PLGA Microspheres
S. Çalış (2004)
10.3109/02652049609052909
Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method.
T. Uchida (1996)
Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteoly
S. amdancioglu (2006)
10.1166/JCSB.2012.1024
Hydrophilic and Fluorescent Colloidal Nanorods of MWNTs as Effective Targeted Drug Carrier
F. Wang (2012)
10.1016/J.IJPHARM.2006.02.044
Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
A. Bernkop-Schnürch (2006)
10.1016/j.ijpharm.2009.10.018
Polymer-based nanocapsules for drug delivery.
C. E. Mora-Huertas (2010)
10.1016/J.MSEC.2009.05.015
A novel PHBV/HA microsphere releasing system loaded with alendronate
W. Huang (2009)
10.1590/S0100-40422009000500016
HIGH ENCAPSULATION EFFICIENCY OF SODIUM ALENDRONATE IN EUDRAGIT S100/HPMC BLEND MICROPARTICLES
L. Cruz (2009)
10.1080/03639040500217624
Biodegradable Microparticulates of Beta-Estradiol: Preparation and In Vitro Characterization
A. Zaghloul (2005)
10.1016/J.IJPHARM.2007.06.002
Pharmacokinetics of raloxifene in male Wistar-Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin.
M. Wempe (2008)
10.1016/S0939-6411(97)00121-5
Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
Y. Kawashima (1998)
Carbopol and chitosan coated
Lu (2011)
Poly(llactide-co- -caprolactone) microspheres laden with bioactive glass-ceramic and alendronate sodium as bone regenerative scaffolds
T. Mondal (2012)
10.1007/s11095-005-8418-y
Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy
S. Hariharan (2005)
10.1166/JBN.2011.1322
Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.
P. Khachane (2011)
10.3109/02652040902751125
Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles
Eliza Główka (2010)
10.1093/AJHP/60.9.883
Current approaches to the prevention and treatment of postmenopausal osteoporosis.
S. L. Follin (2003)
10.1016/J.JCONREL.2004.07.007
Microparticle formation and its mechanism in single and double emulsion solvent evaporation.
I. D. Rosca (2004)
10.1016/S0939-6411(02)00052-8
The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release.
X. Shu (2002)
prepared liposomes loaded with ethinylestradiol
Lu (2011)
10.1166/JBN.2012.1370
Successful strategy for targeting the central nervous system using magnetic albumin nanospheres.
Débora de Oliveira Cintra e Silva (2012)
10.1166/JCSB.2012.1009
Dexamethasone Sodium Phosphate Release from Chitosan Nanoparticles Prepared by Ionic Gelation Method
A. Doustgani (2012)
10.1016/J.SUPFLU.2010.09.023
Formation of submicron poorly water-soluble drugs by rapid expansion of supercritical solution (RESS): Results for Naproxen
M. Türk (2010)
10.4155/TDE.12.40
Polymer-based oral peptide nanomedicines.
E. P. Herrero (2012)
10.1016/j.actbio.2009.01.010
Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
X. Shi (2009)
10.1080/02652040010000334
Characterization of calcitonin-containing liposome formulations for intranasal delivery.
S. Law (2001)
Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
M. Otsuka (2002)
Chromatographic Analysis of Pharmaceuticals, 2nd edition
S. Ebel (1997)
10.1016/j.ijpharm.2012.07.015
Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
A. Paudel (2013)
10.1038/nrd1067
Challenges for the oral delivery of macromolecules
M. Goldberg (2003)
10.1166/JCSB.2012.1022
Reduced Intestinal Toxicity of Docetaxel Loaded Into Mucoadhesive Nanoparticles, in Mouse Xenograft Model
S. Mazzaferro (2012)
10.1166/JBN.2012.1377
Natural lipid nanoparticles containing nimesulide: synthesis, characterization and in vivo antiedematogenic and antinociceptive activities.
R. Raffin (2012)
10.1016/j.ijpharm.2011.05.061
Encapsulation enhancement and stabilization of insulin in cationic liposomes.
S. Park (2011)
Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals.
J. Lin (1991)
10.1021/la1026224
Phase behavior of ketoprofen-poly(lactic acid) drug particles formed by rapid expansion of supercritical solutions.
Muhammad Imran ul-haq (2010)
10.1081/DDC-100000237
Spray-Drying as a Method for Microparticulate Controlled Release Systems Preparation: Advantages and Limits. I. Water-Soluble Drugs
G. Palmieri (2001)
10.1016/j.jconrel.2011.02.030
Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery.
L. Cruz (2011)
10.1016/J.SUPFLU.2012.04.010
Micronisation of carbamazepine through rapid expansion of supercritical solution (RESS)
Dennis Bolten (2012)
10.1002/jbm.a.31989
Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
C. Faucheux (2009)
Polymer-based nanocapsules for drug
C. E. Mora-Huertas (2010)
10.1016/S0301-2115(98)00278-4
Pharmacokinetics of raloxifene and its clinical application.
D. Hochner-Celnikier (1999)
10.1016/J.CARBPOL.2011.03.045
Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends
Puwang Li (2011)
10.1016/j.cis.2011.02.005
Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods critical comparison.
C. E. Mora-Huertas (2011)
10.1016/J.SUPFLU.2004.05.006
Micronization of titanocene dichloride by rapid expansion of supercritical solution and its ethylene polymerization
Jingdai Wang (2005)
10.1002/jbmr.1602
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
N. Binkley (2012)
10.3109/10717541003667830
Microencapsulation of sodium alendronate reduces drug mucosal damage in rats
L. Cruz (2010)
10.1016/j.tibtech.2012.04.008
Colloidal systems for drug delivery: from design to therapy.
Mariana Beija (2012)
10.4155/TDE.12.38
Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
C. Heneweer (2012)
10.1002/JPS.10346
Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats.
Valérie Codrons (2003)
10.1007/s11999-010-1321-9
Calcium Phosphate Cement with BMP-2-loaded Gelatin Microspheres Enhances Bone Healing in Osteoporosis: A Pilot Study
Meng Li (2010)
10.1016/S0169-409X(97)00049-5
Preparation of microspheres by the solvent evaporation technique.
McGinity (1997)
10.1016/S0168-3659(02)00411-X
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
10.1016/j.biomaterials.2007.12.022
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
E. Cenni (2008)
10.1016/J.IJPHARM.2004.07.010
Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
A. Mohammed (2004)
10.1016/J.PROGPOLYMSCI.2011.01.001
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
10.1615/CRITREVTHERDRUGCARRIERSYST.V24.I4.10
Spray-dried powders for pulmonary drug delivery.
P. Seville (2007)
10.1002/1097-4628(20001017)78:3<517::AID-APP60>3.0.CO;2-3
DOXORUBICIN-LOADED POLY(BUTYLCYANOACRYLATE) NANOPARTICLES PRODUCED BY EMULSIFIER-FREE EMULSION POLYMERIZATION
S. C. Yang (2000)
Calcium phosphate drug delivery system : influence of local zoledronate release on bone implant osteointegration
B. Petera (2005)
10.1517/14656566.2011.618123
Current options for the management of postmenopausal osteoporosis
Marie-Paule Lecart (2011)
10.1358/DOT.2009.45.8.1410652
Perspectives in the treatment and prevention of osteoporosis.
L. Gennari (2009)
10.1016/J.MSEC.2012.01.011
Poly (l-lactide-co-Є caprolactone) microspheres laden with bioactive glass-ceramic and alendronate sodium as bone regenerative scaffolds
T. Mondal (2012)
Dexamethasone sodium phosphate release from chitosan naopartilces prepared by ionic gelation method
A. oustgani (2012)
10.4155/TDE.12.18
Liposomes for cardiovascular targeting.
T. Levchenko (2012)
10.1016/J.EJPB.2005.05.009
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
C. Keck (2006)
[Epidemiology of osteoporosis].
J. Bonjour (1997)
10.1016/J.JCONREL.2007.01.016
Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
G. Mittal (2007)
10.2165/00003088-200544060-00001
Pharmacokinetics/Pharmacodynamics of Bisphosphonates
S. Cremers (2005)
[Hormone replacement therapy and osteoporosis].
M. Borovský (2000)
10.1016/j.colsurfb.2011.09.042
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
W. Fan (2012)
Newer research papers are now focusing on the design of phar
Calis (1995)
10.3109/10717544.2011.589085
Ethinylestradiol liposome preparation and its effects on ovariectomized rats’ osteoporosis
Tingli Lu (2011)
10.1007/s11095-008-9759-0
Enhancing Alendronate Release from a Novel PLGA/Hydroxyapatite Microspheric System for Bone Repairing Applications
X. Shi (2008)
Micronization of ibuprofen by Rapid Expansion of Supercritical Solutions(RESS)
김영애 (2007)
10.1166/JCSB.2012.1020
Preparation, Characterization and Applications of Liposomes: State of the Art
A. Laouini (2012)
10.1016/J.POWTEC.2006.09.007
Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles
A. L. R. Rattes (2007)
10.1007/S003960000467
An improved interfacial coacervation technique to fabricate biodegradable nanocapsules of an aqueous peptide solution from polylactide and its block copolymers with poly(ethylene glycol)
Jianbiao Ma (2001)
Osteoporosis : a review of current recommendations and emerging treatment options
A. Makhlof (2011)
Spray-drying a method for microparticulate controlled release systems preparation: advantages and limits. I. Water-soluble drugs
G. F. almieri (2001)
10.1016/S0378-5173(03)00072-3
PLGA microspheres for oral osteopenia treatment: preliminary "in vitro"/"in vivo" evaluation.
P. Perugini (2003)
10.1016/j.biomaterials.2009.07.060
In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents.
D. Sakloetsakun (2009)
10.1016/J.SUPFLU.2011.12.005
Preparation and characterization of raloxifene nanoparticles using Rapid Expansion of Supercritical Solution (RESS)
A. Keshavarz (2012)
10.1016/j.biomaterials.2012.07.039
Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials.
Y. Wang (2012)
10.1080/03639040500528871
Formulation and In Vitro Evaluation of Bisphosphonate Loaded Microspheres for Implantation in Osteolysis
Sibel Samdancioglu (2006)
10.1016/j.ijpharm.2010.03.020
Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
Nobuo Umeki (2010)
prepared n-butyl-acrylate particles by the emulion polymerization technique and found that an increase of the eaction temperature
(2011)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
prepared n-butyl-acrylate particles by the emulion polymerization technique and found that an increase of the eaction temperature
(2011)
10.1016/J.SUPFLU.2006.12.012
Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS)
N. Yıldız (2007)
10.1081/DDC-100100328
Biodegradable Progesterone Microsphere Delivery System for Osteoporosis Therapy
Q. Yang (2000)
10.1002/APP.32789
Doxorubicin loading and in vitro release from poly(alkylcyanoacrylate) nanoparticles produced by redox radical emulsion polymerization
Khairallah Alhareth (2011)
10.1166/JBN.2011.1294
Chitosan coated furosemide liposomes for improved bioavailability.
I. Vural (2011)
10.1166/JCSB.2012.1015
Fluorescent-Labeled Poly( ε -caprolactone) Lipid-Core Nanocapsules: Synthesis, Physicochemical Properties and Macrophage Uptake
Fernanda S. Poletto (2012)
10.3109/10611861003667599
Alendronate-loaded microparticles for improvement of intestinal cellular absorption
J. Baek (2011)
10.1016/j.jconrel.2010.06.016
In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.
C. Kim (2010)
10.1016/j.jsps.2012.05.009
Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.
T. Giri (2013)
10.1080/0265204031000093050
Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: Evaluation of different techniques for the encapsulation of Pamidronate di-sodium salt
U. Weidenauer (2003)
10.1016/S0142-9612(03)00528-3
The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.
G. Wei (2004)
10.4103/0975-7406.84463
Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system
H. Thakkar (2011)
10.1248/CPB.36.1095
A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.
Y. Ogawa (1988)
10.1080/02652040701439807
Alendronate PLGA microspheres with high loading efficiency for dental applications
Eman H Nafea (2007)
Amorphous films of ketoprofen-PLA were also obtained by RESS (Imran
Bolten (2010)
Polymer emulsification process. US Patent 4,177,177
J. W. Vanderhoff (1979)
Osteoporosis: a review of current recommendations and emerging treatment
S. MacBane (2011)
10.1016/J.ADDR.2006.12.001
Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering.
O. R. Davies (2008)
Applications of supercritical CO 2 in the fabrication of polymer systems for drug delivery and tissue engineering ☆
O. R. Davies (2008)
10.1208/pt020310
Long-term release of clodronate from biodegradable microspheres
P. Perugini (2008)
10.1016/j.ijpharm.2010.07.001
Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.
Abdallah Makhlof (2010)
10.1016/j.biomaterials.2011.07.057
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles.
S. Vrignaud (2011)
10.1016/j.addr.2012.01.012
Targeting polymer therapeutics to bone.
Stewart A. Low (2012)
10.1016/J.JCONREL.2004.02.001
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
A. Lamprecht (2004)
10.1016/J.ADDR.2007.02.003
Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas.
K. Mishima (2008)
10.1016/j.ejps.2010.05.001
Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
L. Cruz (2010)
10.1016/0168-3659(94)00060-8
Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin
C. Tasset (1994)
10.1016/J.MATLET.2006.06.062
Fabrication, characterization and long-term in vitro release of hydrophilic drug using PHBV/HA composite microspheres
Yingjun Wang (2007)
10.1002/9781444345100.CH73
Calcium Phosphate Cements in Fracture Repair
R. Leighton (2011)
10.1016/j.ijpharm.2009.04.022
Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
Y. Chen (2009)
10.1007/s000180300002
Colloidal drug carriers: achievements and perspectives
G. Barratt (2003)
10.1016/J.EURPOLYMJ.2008.12.014
Preparation of ASA (acrylonitrile-styrene-acrylate) structural latexes via seeded emulsion polymerization
Shima Tolue (2009)
10.1016/J.APT.2010.08.010
The effects of RESS parameters on the diclofenac particle size
A. Hezave (2011)
10.1097/01.NAJ.0000403358.44058.f7
Prevention and Treatment of Osteoporosis in Postmenopausal Women: A Review
Karen M Roush (2011)
Newer research papers are now focusing on the design of phar
Calis (1995)
10.1016/j.beem.2008.06.001
Epidemiology of osteoporosis.
C. Holroyd (2008)
10.1002/ADMA.200602497
Composite Nanocrystals Provide New Insight on Alendronate Interaction with Hydroxyapatite Structure
Elisa Boanini (2007)
10.1166/JBN.2012.1403
Preparation and biopharmaceutical evaluation of tacrolimus loaded biodegradable nanoparticles for liver targeting.
Salma N. Tammam (2012)



This paper is referenced by
10.3390/COSMETICS3040038
Polyamide Microparticles Containing Vitamin C by Interfacial Polymerization: An Approach by Design of Experimentation
L. Ripoll (2016)
10.1007/978-3-030-00545-0
Natural Products as Source of Molecules with Therapeutic Potential: Research & Development, Challenges and Perspectives
V. Filho (2018)
Élaboration de nanoparticules contenant l’alendronate de sodium pour une application en ostéoporose
K. Miladi (2015)
10.14264/UQL.2015.905
Delivery of therapeutic peptides from thermoplastic polyurethane films
J. Zhang (2015)
10.1038/s41598-018-35197-7
Development of local strontium ranelate delivery systems and long term in vitro drug release studies in osteogenic medium
D. Loča (2018)
10.1002/ADV.21597
Controlled Release Systems Based on Intercalated Paraquat onto Montmorillonite and Clinoptilolite Clays Encapsulated with Sodium Alginate
A. Rashidzadeh (2017)
10.1177/0883911519835142
Pamidronate-encapsulated electrospun polycaprolactone as a potential bone regenerative scaffold
K. Remya (2019)
10.1007/978-3-030-00545-0_11
Development and Use of Polymeric Nanoparticles for the Encapsulation and Administration of Plant Extracts
Ashik Mosaddik (2018)
10.15436/2377-0619.16.047
A Review on Glucocorticoids Induced Osteoporosis: Pathogenesis, Diagnosis and Management by Some Natural Plants.
Walaa G Hozayen (2016)
10.3390/mi9060285
Fab on a Package: LTCC Microfluidic Devices Applied to Chemical Process Miniaturization
Houari Cobas Gomez (2018)
Development of intelligent vehicles for delivery of anti-tumoral drugs
D. Interior (2014)
10.1016/J.INDCROP.2015.02.041
Exploring the potential of Dimorphandra gardneriana galactomannans as drug delivery systems
Raimundo Rafael de Almeida (2015)
10.3390/molecules21070858
Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
L. Ochiuz (2016)
10.7314/APJCP.2014.15.9.3865
Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
A. Aras (2014)
10.1016/j.ijpharm.2013.12.004
Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
Nadiah Zafar (2014)
10.1016/B978-0-12-809436-5.00007-0
Nanocapsule formation by cyclodextrins
S. Gharibzahedi (2017)
10.1016/j.ijpharm.2016.11.002
Encapsulation of NSAIDs for inflammation management: Overview, progress, challenges and prospects.
W. Badri (2016)
10.1016/j.coph.2014.09.003
Emulsion-based techniques for encapsulation in biomedicine, food and personal care.
M. Kakran (2014)
PREPARATION AND OPTIMIZATION OF DICLOFENAC ENCAPSULATED LIPOSOMES USING LIPID HYDRATION TECHNIQUE
M. Rajendar (2014)
10.3389/fbioe.2019.00037
Drug Delivery From Polymer-Based Nanopharmaceuticals—An Experimental Study Complemented by Simulations of Selected Diffusion Processes
I. Macha (2019)
10.1016/j.ijpharm.2015.01.020
Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
Joonho Bae (2015)
10.1007/s11095-020-02793-0
Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation
Bashar M Altaani (2020)
10.1021/acs.molpharmaceut.6b01173
Targeting to the Bone: Alendronate-Directed Combretastatin A-4 Bearing Antiangiogenic Polymer-Drug Conjugates.
Merve Karaçivi (2017)
10.1016/J.COLSURFA.2016.12.029
Effect of process and formulation parameters on polycaprolactone nanoparticles prepared by solvent displacement
Waisudin Badri (2017)
10.1080/09205063.2017.1354675
Construction of a PLGA based, targeted siRNA delivery system for treatment of osteoporosis
Deniz Sezlev Bilecen (2017)
10.1016/j.ijpharm.2015.10.057
Double emulsion solvent evaporation techniques used for drug encapsulation.
M. Iqbal (2015)
10.1002/PEN.23823
On the encapsulation of natural pesticide using polyvinyl alcohol/alginate–montmorillonite nanocomposite for controlled release application
A. Rashidzadeh (2014)
Preparation of submicron particles for theranostic applications : imaging and therapy
M. Iqbal (2015)
10.17877/DE290R-15560
Particles from preformed polymers as carriers for drug delivery
K. Miladi (2014)
10.12865/CHSJ.41.03.09
Formulation and In Vitro Evaluation of Alendronate Sodium/PLGA Microspheres for Applications in Bone Related Disorders
A. Deca (2015)
10.1016/J.JDDST.2015.04.007
Enhancement of alendronate encapsulation in chitosan nanoparticles
Karim Miladi (2015)
10.3109/03639045.2014.956111
Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance
Jafar Ezzati Nazhad Dolatabadi (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar